In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Bill Carpou, CEO of Octane, to discuss his transition to executive chairman of the organization.
· Tell us about your background. 2:24
· How has Octane changed under your leadership? What does the future hold? 4:01
· What does Octane do? 8:57
· What will be different, and what will remain the same? 12:07
· What are the differences between ophthalmology/optometry and other specialties? 15:20
· What trends are you seeing in eye care? 18:08
· What is causing the slowdown of cataract procedures? 20:21
We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn. To find out more about Octane, click here.
Disclosures: Carpou reports being CEO of Octane. Hovanesian reports consulting widely in the ophthalmic field and being a strategic medical advisor for Tenpoint Therapeutics. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Lab, Bain Capital, CVC Capital Partners and Zeiss; being executive chairman of Neurotech, Preceyes BV and TearLab; and sitting on the board of Centricity Vision, Crystilex, LensGen and Visus.
30 Sept 2026
Live from SightLine 2026: Experts discuss myopia, AI-assisted cataract surgery
In this last episode from ASCRS 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Perry J. Sternberg of Sydnexis, Nancy Beesley, and Jean-Pierre Hubschman, MD, of Horizon Surgical Systems, to discuss myopia in children, cataract surgery assisted by AI and robotics, and more.
· Welcome Perry J. Sternberg and Nancy Beesley. 0:44
· How and why is SYD-101 different from atropine? 3:20
· What happened with the FDA approval? 8:24
· Tell us about the study. 10:57
· Welcome Jean-Pierre Hubschman, MD. 20:32
· Transitioning from retina to cataracts. 21:02
· How do you address concerns about AI replacing surgeons? 24:19
· Transitioning from physician to CEO. 28:46
We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram (https://www.instagram.com/drhovanesian/) and X (https://x.com/DrHovanesian) and John Hovanesian on LinkedIn.
8 Sept 2026
Sitting down with the newest CEO of STAAR Surgical, Warren Foust
In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Warren Foust, the newest CEO and president of STAAR Surgical. They discuss changing careers, what it's like to find yourself in a leadership position and more.
· Introducing Warren Foust 0:44
· What advice would you give others about becoming a leader in ophthalmology? 7:13
· What did you learn throughout this process of change? 10:00
· What plans do you have for the future? 12:46
· How do you define innovation? 14:52
We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram (https://www.instagram.com/drhovanesian/) and X (https://x.com/DrHovanesian) and John Hovanesian on LinkedIn.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
5 ratings
Podcast Authority Score: 34 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
41
Social presence
0
YouTube
0
Engagement
68
Contact Eyeluminaries
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
